Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.

Бусад хувилбаруудыг харуулах (1)

New tuberculosis vaccines are urgently needed to curtail the current epidemic. MVA85A is a subunit vaccine that could enhance immunity from BCG vaccination. To determine MVA85A safety and immunogenicity as well as interactions with other routine vaccines administered in infancy, we randomized health...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Ota, M, Odutola, A, Owiafe, P, Donkor, S, Owolabi, O, Brittain, N, Williams, N, Rowland-Jones, S, Hill, A, Adegbola, R, McShane, H
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2011

Ижил төстэй зүйлс

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
-н: Ota, M, зэрэг
Хэвлэсэн: (2011)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
-н: Odutola, A, зэрэг
Хэвлэсэн: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
-н: Odutola, A, зэрэг
Хэвлэсэн: (2012)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
-н: Brookes, R, зэрэг
Хэвлэсэн: (2008)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
-н: Roger H Brookes, зэрэг
Хэвлэсэн: (2008-08-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
-н: Roger H. Brookes, зэрэг
Хэвлэсэн: (2011-01-01)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
-н: Rowland, R, зэрэг
Хэвлэсэн: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
-н: Pathan, A, зэрэг
Хэвлэсэн: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
-н: Pathan, A, зэрэг
Хэвлэсэн: (2012)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
-н: Meyer, J, зэрэг
Хэвлэсэн: (2013)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
-н: Whelan, K, зэрэг
Хэвлэсэн: (2009)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
-н: Owiafe, P, зэрэг
Хэвлэсэн: (2012)

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
-н: Ibanga, H, зэрэг
Хэвлэсэн: (2006)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
-н: Meyer, J, зэрэг
Хэвлэсэн: (2013)

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
-н: Imoukhuede, E, зэрэг
Хэвлэсэн: (2006)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
-н: White, A, зэрэг
Хэвлэсэн: (2013)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
-н: Harris, S, зэрэг
Хэвлэсэн: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
-н: Sander, C, зэрэг
Хэвлэсэн: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
-н: Kathryn T. Whelan, зэрэг
Хэвлэсэн: (2011-01-01)

Safety and immunogenicity of malaria vectored vaccines given with routine EPI vaccines in Gambian infants and neonates: a randomized controlled trial
-н: Mensah, V, зэрэг
Хэвлэсэн: (2017)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
-н: Mcshane, H
Хэвлэсэн: (2008)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
-н: Dieye, T, зэрэг
Хэвлэсэн: (2013)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
-н: Hawkridge, T, зэрэг
Хэвлэсэн: (2008)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
-н: Satti, I, зэрэг
Хэвлэсэн: (2014)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Хэвлэсэн: (2011-01-01)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
-н: Rowland, R, зэрэг
Хэвлэсэн: (2013)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
-н: Mcshane, H, зэрэг
Хэвлэсэн: (2016)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
-н: Minassian, A, зэрэг
Хэвлэсэн: (2011)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
-н: Scriba, T, зэрэг
Хэвлэсэн: (2011)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
-н: Wajja, A, зэрэг
Хэвлэсэн: (2017)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
-н: Anne Wajja, зэрэг
Хэвлэсэн: (2017-05-01)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
-н: Tandakha N Dieye, зэрэг
Хэвлэсэн: (2013-01-01)

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.
-н: Mullarkey, C, зэрэг
Хэвлэсэн: (2013)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
-н: Thomas, Z, зэрэг
Хэвлэсэн: (2014)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
-н: Tandakha N. Dieye, зэрэг
Хэвлэсэн: (2013-01-01)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
-н: Satti, I, зэрэг
Хэвлэсэн: (2014)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
-н: Mcshane, H, зэрэг
Хэвлэсэн: (2005)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
-н: Minhinnick, A, зэрэг
Хэвлэсэн: (2016)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
-н: Tameris, M, зэрэг
Хэвлэсэн: (2014)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
-н: Griffiths, K, зэрэг
Хэвлэсэн: (2011)